Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Co-Clinical Evaluation of Synthetic Vitamin D and Chemotherapy in Pancreatic Cancer by Integrated Imaging and Molecular Analyses.
Journal: Cancer research communications
Published: June 30, 2026
Evaluating the Safety and Efficacy of Adding Liver-Directed Radiation Therapy to Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: A Single-Center Retrospective Cohort Analysis.
Journal: American journal of clinical oncology
Published: April 30, 2025
A phase 1 dual-dose escalation study of radiation and nab-paclitaxel in patients with unresectable and borderline resectable pancreatic cancer.
Journal: Cancer
Published: February 20, 2025
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.
Journal: Nature cancer
Published: January 01, 2025
A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 05, 2024
Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab.
Journal: JCO clinical cancer informatics
Published: August 01, 2024
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer.
Journal: Future oncology (London, England)
Published: June 17, 2024
Clinical outcomes and risk stratification in unresectable biliary tract cancers undergoing radiation therapy.
Journal: Radiation oncology (London, England)
Published: February 28, 2024
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors.
Journal: Cancer research communications
Published: February 09, 2024
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma.
Journal: Nature communications
Published: December 05, 2023
Oral Carbon Monoxide Enhances Autophagy Modulation in Prostate, Pancreatic, and Lung Cancers.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 02, 2023
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.
Journal: Nature medicine
Published: October 18, 2023
Last Updated: 09/26/2026